LTGO

Latigo Biotherapeutics

Company identity has not yet been verified

Browse linked trials and recorded changes, or follow this company for updates.

2Trials in this database

5Recorded changes · last 12 months

Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source

Trial	Sponsor	Phase	Status	Primary completion
This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third MolarsNCT06774625	Latigo Biotherapeutics	Phase 2	Completed	2025-08-08Actual
An Efficacy and Safety Study of LTG-001 Following AbdominoplastyNCT07102459	Latigo Biotherapeutics	Phase 2	Completed	2026-01-07Actual

This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars

Latigo BiotherapeuticsCompletedPrimary completion: 2025-08-08 · Actual

Trial details

Registry ID: NCT06774625
Phase: Phase 2

An Efficacy and Safety Study of LTG-001 Following Abdominoplasty

Latigo BiotherapeuticsCompletedPrimary completion: 2026-01-07 · Actual

Trial details

Registry ID: NCT07102459
Phase: Phase 2

− Before

~~Recruiting~~

+ After

Completed

Check registry source